Table 2.
Participant characteristics by individual study and for all studies combined
| Study ID | n | Sex† | Education‡ § | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (years)* | Male | Female | None | Primary | Secondary | HIV(+)‖ | ||||||||||
| Min–Max | Mean | sd | n | % | n | % | n | % | n | % | n | % | n | % | ||
| ARG | 204 | 18·4–50·6 | 31 | 7·1 | 179 | 88 | 25 | 12 | 8 | 4 | 159 | 78 | 37 | 18 | 69 | 34 |
| BAN | 650 | 19–60 | 27·7 | 7·4 | 260 | 40 | 390 | 60 | 171 | 26 | 194 | 30 | 285 | 44 | Not tested | |
| GUI-HIV | 1055 | 18–76 | 37·5 | 10·9 | 313 | 30 | 742 | 70 | No data | 1055 | 100 | |||||
| GUI-TBC | 769 | 18–90 | 33·1 | 13·8 | 335 | 44 | 434 | 56 | 101 | 13 | 240 | 31 | 428 | 56 | Not tested | |
| IND-BKW | 501 | 18–74 | 36·6 | 11·6 | 501 | 100 | 0 | 0 | 338 | 68 | 40 | 8 | 123 | 25 % | Not tested | |
| IND-FSD | 333 | 18–80 | 34·2 | 14 | 0 | 0 | 333 | 100 | 196 | 59 | 123 | 37 | 14 | 4 | Not tested | |
| IND-IDU | 374 | 22–61 | 38·7 | 7·2 | 374 | 100 | 0 | 0 | 85 | 23 | 222 | 59 | 67 | 18 | 178 | 48 |
| IND-MSD | 474 | 18–84 | 37·5 | 14·2 | 474 | 100 | 0 | 0 | 136 | 29 | 148 | 31 | 190 | 40 | Not tested | |
| IND-ORA | 205 | 18–70 | 38 | 13·4 | 205 | 100 | 0 | 0 | No data | Not tested | ||||||
| IND-SDW | 992 | 18–85 | 35·9 | 14·5 | 490 | 49 | 502 | 51 | 368 | 37 | 239 | 24 | 384 | 38 | Not tested | |
| IND-UNI | 599 | 18–28 | 22·1 | 1·6 | 228 | 38 | 371 | 62 | 0 | 0 | 0 | 0 | 599 | 100 | Not tested | |
| MAL-HNW | 329 | 18–57 | 33·9 | 8·1 | 122 | 37 | 206 | 63 | No data | 329 | 100 | |||||
| MAL-HWW | 186 | 18–58 | 34·1 | 9 | 56 | 30 | 130 | 70 | No data | 186 | 100 | |||||
| NAM | 407 | 18–74 | 29·9 | 9·7 | 236 | 58 | 171 | 42 | 36 | 9 | 39 | 10 | 331 | 82 | 73 | 18 |
| SAF | 283 | 60–91 | 71·5 | 7·9 | 53 | 19 | 230 | 81 | No data | Not tested | ||||||
| USA-HIV | 553 | 24·1–75·4 | 46·1 | 7·9 | 372 | 67 | 181 | 33 | 0 | 0 | 6 | 1 | 547 | 99 | 553 | 100 |
| USA-IDU | 520 | 22–67·8 | 43·8 | 7·5 | 335 | 64 | 185 | 36 | 187 | 36 | 206 | 40 | 123 | 24 | 284 | 55 |
| VIE-FEM | 4922 | 18–44·7 | 26·4 | 4·5 | 0 | 0 | 4922 | 100 | 0 | 0 | 404 | 8 | 4516 | 92 | Not tested | |
| VIE-IDU | 297 | 19–46·9 | 31·2 | 5·2 | 297 | 100 | 0 | 0 | 1 | 0 | 3 | 1 | 293 | 99 | 202 | 68 |
| ZAM | 182 | 20–49 | 33·2 | 7·7 | 91 | 50 | 91 | 50 | No data | 182 | 100 | |||||
| COMBINED¶ | 13 835 | 18–91 | 32·6 | 12·1 | 4921 | 36 | 8913 | 64 | 1627 | 14 | 2023 | 18 | 7937 | 69 | 3111 | 23 |
*
Number of participants missing data on age: MAL-HNW (n 4), MAL-HWW (n 1), SAF (n 5), USA-IDU (n 9), VIE-FEM (n 23), VIE-IDU (n 1).
†
Number of participants missing data on sex: MAL-HNW (n 1).
‡
Number of participants missing data on education: IND-SDW (n 1), NAM (n 1), USA-IDU (n 4), VIE-FEM (n 2).
§
For USA-IDU, categories are <high school, some high school, >high school.
‖
For NAM, HIV status based on self-report; for VIE-IDU, n 1 missing data on HIV status.
¶
Statistics for the combined datasets for education and HIV status exclude studies that did not collect data on these variables.